Home > Boards > US OTC > Biotechs > Revance Therapeutics, Inc. (RVNC)

Still, I doubt that the ALDR buyout is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Fred Kadiddlehopper Member Profile
 
Followed By 24
Posts 3,477
Boards Moderated 1
Alias Born 09/22/06
160x600 placeholder
Revance to Participate in the Stifel 2019 Healthcare Conference Business Wire - 11/12/2019 4:05:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/12/2019 11:28:39 AM
Revance to Participate in the Credit Suisse 28th Annual Healthcare Conference Business Wire - 11/6/2019 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2019 4:23:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 4:23:25 PM
Revance Reports Third Quarter 2019 Financial Results, Provides Corporate Update Business Wire - 11/4/2019 4:10:00 PM
Revance Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia Business Wire - 11/4/2019 4:05:00 PM
Revance Announces Publication of SAKURA 1 and SAKURA 2 Results in Plastic and Reconstructive Surgery Business Wire - 11/4/2019 8:00:00 AM
Revance to Release Third Quarter 2019 Financial Results on Monday, November 4, 2019 Business Wire - 10/28/2019 4:05:00 PM
Revance to Present Clinical Data Highlighting the Efficacy and Safety of DAXI at the ASDS 2019 Annual Meeting Business Wire - 10/23/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 8:18:44 AM
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne Business Wire - 10/14/2019 8:00:00 AM
Revance Earns Great Place to Work® Certification for Second Year Business Wire - 10/2/2019 4:05:00 PM
Revance to Participate in the 2019 Cantor Global Healthcare Conference Business Wire - 9/25/2019 4:05:00 PM
Revance to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference Business Wire - 9/4/2019 4:05:00 PM
Revance to Participate in the Wells Fargo 14th Annual Healthcare Conference Business Wire - 8/28/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 8:23:39 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/12/2019 4:10:23 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:18:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 4:09:22 PM
Revance Reports Second Quarter 2019 Financial Results, Provides Corporate Update Business Wire - 8/5/2019 4:05:00 PM
Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019 Business Wire - 7/29/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2019 8:05:54 AM
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors Business Wire - 7/17/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 7:35:43 PM
Fred Kadiddlehopper   Tuesday, 09/17/19 04:27:57 PM
Re: DewDiligence post# 1178
Post # of 1299 
Quote:
Still, I doubt that the ALDR buyout is the main impetus for RVNC’s recent uptrend.



Agreed in so far as the rebound started before the recent buyout news.


The more you know, the less you don't know.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist